About X-Chem
X-Chem is a company based in Waltham (United States) founded in 2009 was acquired by Enko Chem in June 2022. X-Chem has raised $8.5 million across 1 funding round from investors including PPD, Enko Chem and GHO Capital. The company has 51 employees as of December 31, 2022. X-Chem has completed 4 acquisitions, including Avisyn, ComInnex and Glamorous AI. X-Chem offers products and services including DEL Screening, ReadiDEL, ReadiBLOX, and ArtemisAI. X-Chem operates in a competitive market with competitors including STRmix, The Total Body Approach and DeepCodex, among others.
- Headquarter Waltham, United States
- Employees 51 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name X-Chem Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of X-Chem
X-Chem offers a comprehensive portfolio of products and services, including DEL Screening, ReadiDEL, ReadiBLOX, and ArtemisAI.
Service for screening DNA-encoded libraries to identify drug candidates.
Pre-built DNA-encoded library for rapid drug discovery research.
Modular building blocks for custom medicinal chemistry applications.
AI tool for analyzing molecular interactions in drug development.
People of X-Chem
Unlock access to complete
Funding Insights of X-Chem
X-Chem has successfully raised a total of $8.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.5 million completed in December 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in X-Chem
X-Chem has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include PPD, Enko Chem and GHO Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Specialist healthcare investment advisory services are provided by GHO Capital.
|
Locked | Locked | Locked | |
|
CRO providing diversified clinical development services
|
Locked | Locked | Locked | |
|
Develops and supplies agriculture crop inputs
|
Locked | Locked | Locked |
Investor details for X-Chem
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by X-Chem
X-Chem has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Avisyn, ComInnex and Glamorous AI.
Investment portfolio details for X-Chem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Preclinical studies for biopharma drug discovery are conducted.
|
Locked | Locked | 2020 | Locked | |
|
Scientific sourcing services are offered by Avisyn as a CRO.
|
Locked | Locked | 2016 | Locked | |
|
CRO offers synthetic, computational, analytical and in vitro and in vivo drug discovery services
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for X-Chem
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - X-Chem
Detailed financials for X-Chem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
X-Chem Comparisons
Peer comparison for X-Chem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of X-Chem
X-Chem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as STRmix, The Total Body Approach and DeepCodex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops software for forensic DNA profile analysis, interpretation, and evidence processing.
|
|
| Locked | Locked | Locked |
Music producer creating remixes, new releases, and podcasts for fan engagement.
|
|
| Locked | Locked | Locked |
Web app for searching gene expression data and genetic manipulations.
|
Detailed competitors of X-Chem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on X-Chem
Complete news archive for X-Chem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about X-Chem
X-Chem was founded in 2009 and raised its 1st funding round 3 years after it was founded.
X-Chem is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
X-Chem is a funded company, having raised a total of $8.5M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at X-Chem is 51.
X-Chem was founded in 2009 and is based in Waltham, United States. Operations center on a biotechnology platform for small molecule drug discovery, known as DNA-Encoded X-Chem (DEX). Libraries of small molecules tethered to DNA tags, which track synthetic history, are generated through combinatorial synthesis. These mixtures are screened via affinity binding to targets, with bound compounds detected by DNA sequencing for therapeutic development.
X-Chem's top competitors include STRmix, The Total Body Approach and DeepCodex.
X-Chem offers DEL Screening, ReadiDEL, ReadiBLOX, and ArtemisAI.
X-Chem has made 4 acquisitions, including Avisyn, ComInnex, and Glamorous AI.
X-Chem has 3 investors. Key investors include PPD, Enko Chem, and GHO Capital.